Clinical Trials Directory

Trials / Unknown

UnknownNCT03564002

Metabolic Effects of Very Low Carbohydrate Ketogenic Diet in Subjects With Severe Obesity

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
University Of Perugia · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The very low carbohydrates diet (VLCKD) induces liver steatosis amelioration. Lysosomal acid lipase (LAL) deficiency plays a role in fats accumulation in liver. To date, no studies have assessed LAL activity in morbid obesity. The aim of our study is to evaluate VLCKD impact on metabolic/vascular parameters and LAL activity in obese patients. A VLCKD is administered for 25 days to 52 morbid obese patients (BMI 44.7±8.3 kg/m², age 49±12.5 years); at baseline and after diet we evaluated: BMI, glyco-lipidic pattern, abdominal ultrasonography (liver steatosis and visceral fat area) and flow-mediated dilation (FMD). In a subgroup of 20 patients we also tested lysosomal acid lipase (LAL)-activity. A group of healthy normal weight subjects (age 43±13, BMI 22.8±2.6 kg/m²) was also included in the study.

Conditions

Timeline

Start date
2016-10-01
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2018-06-20
Last updated
2020-03-09

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03564002. Inclusion in this directory is not an endorsement.

Metabolic Effects of Very Low Carbohydrate Ketogenic Diet in Subjects With Severe Obesity (NCT03564002) · Clinical Trials Directory